Published in Medical Verdicts and Law Weekly, November 22nd, 2007
From the beginning, DBS maintained that neither the PACran product nor its unique method of manufacture infringed Bio-Nutra's patent. Following an extensive pre-trial factual investigation that supported DBS's position, Bio-Nutra has now agreed to dismiss its claims against DBS and has signed an agreement not to bring similar lawsuits against DBS in the future. The...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Verdicts and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.